Research reveals aspirin is safe for heart surgery patients

February 25, 2016
Professor Paul Myles

A worldwide study led by Monash University clinician-researchers shows that patients who take aspirin before heart surgery are at no greater risk of bleeding or complications. 

Published 25 February in the New England Journal of Medicine, the collaborative research study led by Professor Paul Myles, Head of the Department of Anaesthesia and Perioperative Medicine in the Central Clinical School and Alfred Health, investigated whether stopping or continuing before posed more risks or benefits.

Most patients with receive aspirin for prevention of heart attack, stroke, and death. However aspirin poses a bleeding risk for patients undergoing surgery, and prior to this study it was unclear whether aspirin should be stopped before coronary artery surgery.

Professor Myles said until recently, ceasing aspirin five to seven days before surgery has been traditional practice in most cardiac surgical centres.

"Until now, conflicting guidelines from expert professional organisations highlight the lack of evidence to determine if the increased risk of surgical bleeding could be outweighed by a beneficial effect of aspirin," said Professor Myles.

Study co-author and Head of Surgery at the School of Clinical Sciences at Monash HealthProfessor Julian Smith said "The study found the use of aspirin, as compared with placebo, before coronary artery surgery did not reduce the risk of death and thrombotic complications.

"Preoperative aspirin exposure did not increase surgical bleeding, transfusion requirements or need for re-operation and there is therefore no reason to stop aspirin before coronary artery surgery," Professor Smith added.

The researchers evaluated the benefits and bleeding risks of aspirin at a dose of 100mg, the dose deemed to have the strongest evidence of efficacy balanced against a low risk of bleeding complications.

"We wanted to determine whether it was best to stop or continue aspirin in patients undergoing because the blood-thinning (or anti-coagulant) properties of aspirin are well-established," said co-author and Head of School of Public Health and Preventive Medicine Professor John McNeil.

"Stopping aspirin five to seven days before surgery increases thrombotic risk before the benefits of bypass grafting can be achieved and sometimes surgery is cancelled or delayed exposing the patient to increased thrombotic risk," added Professor Myles.  

"Withdrawal of aspirin in patients scheduled for surgery to reduce risk could be harmful."

2100 across five countries in 19 participating hospitals were enrolled and randomly assigned to the research project.

Explore further: New study shows patients with coronary artery disease

More information: Stopping vs. Continuing Aspirin before Coronary Artery Surgery. DOI: 10.1056/NEJMoa1507688

Related Stories

New study shows patients with coronary artery disease

August 30, 2011
Thrombotic (clotting) and bleeding events are complications that may occur after surgery. With the aging population in the western world, there are more patients undergoing orthopedic surgery than ever before. This makes ...

Major bleeds rise with perioperative aspirin for non-cardiac surgery

March 31, 2014
Patients given aspirin to prevent heart problems after non-heart-related surgery had a higher risk of serious bleeding than the patients who did not receive aspirin. At the same time, aspirin did not reduce incidence of post-operative ...

Preoperative aspirin therapy can benefit cardiac surgery patients

December 5, 2011
Aspirin taken within five days of cardiac surgery is associated with a significant decrease in the risk of major postoperative complications, including renal failure, a lengthy intensive care unit stay and even early death ...

OK to continue aspirin therapy up to pancreatic surgery

August 1, 2013
(HealthDay)—Patients on aspirin therapy do not have higher rates of perioperative bleeding, transfusion, or major procedure-related complications following elective pancreatic surgery, according to research published online ...

Aspirin or blood pressure medication before and after surgery does not reduce risk of AKI

November 15, 2014
In patients undergoing noncardiac surgery, neither aspirin nor clonidine (a medication primarily used to treat high blood pressure) taken before and after surgery reduced the risk of acute kidney injury, according to a study ...

Even low-dose aspirin may increase risk of GI bleeding

September 12, 2011
The risk of gastrointestinal (GI) bleeding needs to be considered when determining the potential preventive benefits associated with low-dose aspirin for cardiovascular disease and cancer. According to a new study in Clinical ...

Recommended for you

Low-salt and heart-healthy dash diet as effective as drugs for some adults with high blood pressure

November 22, 2017
A study of more than 400 adults with prehypertension, or stage 1 high blood pressure, found that combining a low-salt diet with the heart-healthy DASH diet substantially lowers systolic blood pressure—the top number in ...

Stroke patients may have more time to get treatment, study finds

November 22, 2017
Patients and doctors long have relied on a simple rule of thumb for seeking care after an ischemic stroke: "Time is brain."

Cases of heart failure continue to rise; poorest people worst affected

November 22, 2017
The number of people being diagnosed with heart failure in the UK continues to rise as a result of demographic changes common to many developed countries, new research by The George Institute for Global Health at the University ...

Some cancer therapies may provide a new way to treat high blood pressure

November 20, 2017
Drugs designed to halt cancer growth may offer a new way to control high blood pressure (hypertension), say Georgetown University Medical Center investigators. The finding could offer a real advance in hypertension treatment ...

Could this protein protect people against coronary artery disease?

November 17, 2017
The buildup of plaque in the heart's arteries is an unfortunate part of aging. But by studying the genetic makeup of people who maintain clear arteries into old age, researchers led by UNC's Jonathan Schisler, PhD, have identified ...

Raising 'good' cholesterol fails to protect against heart disease

November 16, 2017
Raising so-called 'good' cholesterol by blocking a key protein involved in its metabolism does not protect against heart disease or stroke, according to a large genetic study of 150,000 Chinese adults published in the journal ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.